PhD
Personal Chair
- About
-
- Email Address
- f.thies@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437954
- Office Address
School of Medicine, medical Sciences and Nutrition, Rowett Institute, Foresterhill Aberdeen AB25 2ZD
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
Frank Thies graduated in animal Physiology from the University of Burgundy (France) in 1987 before undertaking a PhD in Nutritional Physiology, also at the University of Burgundy and awarded in 1991. Dr Thies then completed a 3 year Postdoctoral Fellowship at the National Institute of Health (Bethesda, USA) before joining Prof Philip Calder's group within the Department of Biochemistry at Oxford University. In 1998, he moved to the University of Southampton before taking a lecturer position in Human Nutrition at the University of Aberdeen in 2001. Dr Thies was then promoted to Senior lecturer in 2005, and Reader in 2013.
Memberships and Affiliations
- Internal Memberships
-
Deputy Director, (Rowett Institute)
Teaching lead (Rowett Institute)
Member, Rowett Institute executive committee
Member of University of Aberdeen Senate (2015-2018)
- External Memberships
-
External Examiner, Glasgow Caledonian University (2007-2012)
External Examiner, Queen Margaret University (2008-2013)
External Examiner, Northumbria University (2013-2017)
External Examiner, Ulster University (2017-2021)
Secretary, Scottish Section of the Nutrition Society (2011-2014)
Member, Council, The Nutrition Society (2011-present)
Member, Scientific Commitee, The Nutrition Society (2011-2014)
Honorary Science Officer and Trustee, the Nutrition Society (2015-2021)
Trustee, the Academy of Nutrition Sciences (2019-present)
Teasurer, Federation of European Nutrition Societies (2019-present)
- Research
-
Research Overview
 Â
My research interests mainly relate to the influence of various dietary components on cardiovascular function and cardiovascular risk, with particular emphasis being placed on the role of inflammatory processes. My research activities include relatively large as well as pilot intervention studies in healthy individuals and patients, supported by in vitro work for the mechanistic aspects. Other current projects relates to identifying methods for beneficially changing eating behaviour in low income populations via social prescribing, in order to reduce health inequalities.
Supervision
- “Compilation, validation and implementation of an anti-inflammatory diet” by Adrian Wood. Awarded November 2007.
- “atherosclerosis, fibrosis and nutrition: effect of n-3PUFA on smooth muscle activity and relevance to atherosclerosis” by Claire White. Awarded January 2009
- “Effects of fish oil on epoxyeicosatrieonic acid metabolism: relevance to inflammation and vascular function” by Yiannis Mavromatis. Awarded January 2009
- “Effect of lycopene on immune cell function and activity” by Lynsey Mills, Awarded June 2010
- “Effect of Regular Mealtime Inclusion of Oat Containing Products on Glycaemic Response and Postprandial Inflammation in Early Type 2 Diabetes” by Susan Christina McGeoch, Awarded October 2011
- “Improving Insulin Sensitivity and Preventing Diabetes by Altering Muscle Membrane Fatty Acid Composition” by Louise Frances Clark, Awarded October 2014
- “Effects of Oat Products on Human Colonic Health” by Andrew John Chappell (Co-lead) October 2015
- “The Effects of Nitrite on Muscle Metabolic Efficiency and its Relevance to Cardiac Disease” by Maria Ntessalen (Co-supervisor), November 2015
- Modulation of Dimethylarginine Dimethylaminohydrolase (DDAH) as a Therapeutic Target in Neurodegenerative Disorders” by Sara Tommasi (Co-supervisor), awarded July 2016.
- ”Influence of short chain fatty acids on blood pressure regulation”, by Karolin Musz, awarded April 2017.
- “Investigating the effects of dietary-derived and sunlight-derived vitamin D3 on markers of immune function” by Wakuny Ambo Maboshe, awarded May 2018.
- Marine-derived n-3 fatty acids: a potential therapeutic target for stroke? by Celia Alvarez-Campano, awarded 25 May 2020
- Study and impact of zinc in haemostasis by Sumya Um-May, awarded 28th September 2020
Funding and Grants
Grant income since 2005: >£4millions
2004-2007- PhD scholarship, Food Standard Agency (G Duthie, F Thies)
2005-2007- Effect of n-3 PUFA on platelet activation, markers of inflammation and endothelial dysfunction in patients with peripheral arterial disease, British Heart foundation, (J Brittenden, F. Thies, I. Ford, M. Greaves)
2005-2008- Effect of whole grain food on CVD risk markers, Food Standard Agency, (F Thies, G. Duthie, J. Brittenden)
2006- Diet, aspirin and platelets aggregation in patients with peripheral arterial disease NHS Grampian Endowments (J Brittenden, F Thies)
2007-2010- Tomato, lycopene, and CVD risk, Food Standard Agency, (F Thies, G. Duthie, L Masson)
2008-2009- Development of a method to measure methylated derivatives of arginine in plasma , Development Trust, (F. Thies, J. Brittenden, G. Cameron)
2007-2009- Imaging atherosclerotic plaque inflammation with flurodeoxyglucose positron emisson tomography and CT angiography TMRI Ltd (J Brittenden, K Cassar, F Thies)
2008-2011- Effect of 1 year vitamin D intervention on risk of cardiovascular disease: a randomized controlled trial at 57ºN, Food Standard Agency (H MacDonald, F Thies, A Mavroiedi, D Reid)
2008-2009- In Vivo 18-FDG PET Imaging and Atherosclerotic Plaque Inflammatory Biomarkers in Mouse Model of Atherosclerosis- A Randomized Controlled Trial TMRI Ltd (J Brittenden, S Shaikh, G Small, H Wilson , A Welch, F Thies, P Brown)2009-2012- A comprehensive longitudinal study of diet and chronic low-grade systemic inflammation in a well-characterized population of postmenopausal women Food Standard Agency (H MacDonald, F Thies, D Reid, G Duthie)
2010- Fish oil supplementation and immune function and inflammatory responses to exerciseTenovus Scotland (S Gray, F Thies)
2011-2012-Development of novel DDAH inhibitors for the treatment of neurodegenerative diseases SULSA Pooling network (A Mangoni, I Creig, F Thies , P Teismann, M Zanda)
2011-2012-Dimethylarginine dimethylamino hydrolase (DDAH) modulation as a potential therapeutic target in Alzheimer’s disease:a pilot study. Alzeihmer’s research trust (A Mangoni, F Thies, R Soiza)
2011-2012- Can ADMA predict cognitive decline? NHS Grampian endowments (A Mangoni, R Soiza, F Thies)
2011-2015- Strategic partnership on food and drink science, Scottish Government (K Scott, F Thies, M Frenneaux)
2016-2018- Muscle fat compartments and turnover as a determinant of insulin sensitivity. British heart Foundation (D Dawson, M Delibegovic, F Thies)
2017-2018- DHA supplementation as a treatment for ischaemic stroke (DASTIS). NHS Grampian Endowment (MJ MacLeod, M. J. & F Thies)
2018-2022-Modelling individual responses to healthier diets and new ways to quantify the importance of physiology and behaviour for successful dietary changes. BBSRC database 39358/Unilever studentship, BBSRC (B de Roos & F Thies)
2018-2022- Modelling individual responses to healthier diets and new ways to quantify the importance of physiology and behaviour for successful dietary changes. BBSRC database 39364/Unilever studentship, Unilever R&D/Vlaardingen (B de Roos & F Thies)
2018-2022- Using wearable technology to optimise timing of concomitant metformin and exercise prescription. NHS Grampian Endowments (B Gabriel, F Thies, S Philips)
2021-2022- Newton fund: exploitation of mesquite tree as a sustainable source of food with high nutritional and economicl value in the mezquital valley, Hidalgo. British Council, Newton Fund (F Thies, W Russel, N Hoggard, V Raikos)
- Teaching
-
Teaching Responsibilities
Teaching of nutritional physiology and biochemistry at undergraduate (exercise physiology (year 3) and year1 MBChB (year 1) and postgraduate level (MSc Human nutrition and MSc cardiovascular and diabetes).
MSc Human Nutrition & Metabolism programme coordinator 2001-2007
MSc Molecular Nutrition course coordinator 2010-2014
MSC Metabolic nutrition course coordinator 2014
MSc Human Nutrition Research project course coordinator 2015-2017
MSc Assessment of nutritional status course coordinator 2018-present
Teaching Lead, Rowett Institute (2022-)
- Publications
-
Page 1 of 4 Results 1 to 50 of 166
Guidance on the scientific requirements for an application for authorisation of a novel food in the context of Regulation (EU) 2015/2283
EFSA Journal, vol. 22, no. 9, e8961Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.2903/j.efsa.2024.8961
Comparison of intramyocellular lipid metabolism in patients with diabetes and male athletes
Nature Communications, vol. 15, no. 1, pp. 3690Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.6084/m9.figshare.24219934
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/23599/1/Mezincescu_etal_Comparison_intramyocellular_lipid_VOR.pdf
- [ONLINE] View publication in Scopus
- [ONLINE] https://abdn.elsevierpure.com/en/publications/32def9dd-91e5-4a39-8c0d-7bbdc7cc4c91
Morning exercise and pre-breakfast metformin interact to reduce glycaemia in people with type 2 diabetes: a randomized crossover trial
The Journal of PhysiologyContributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1113/JP285722
Safety of isomaltulose syrup (dried) as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal, vol. 22, no. 1, e8491Contributions to Journals: ArticlesSafety of lacto-N-fucopentaose I/2'-fucosyllactose (LNFP-I/2'-FL) mixture as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal, vol. 21, no. 12, e8412Contributions to Journals: ArticlesSafety of oil from Schizochytrium limacinum (strain TKD-1) for use in infant and follow-on formula as a novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 12, e8414Contributions to Journals: ArticlesSafety of oil from Schizochytrium sp. (strain CABIO-A-2) for use in infant and follow-on formula as a novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 12, e8415Contributions to Journals: ArticlesScientific opinion on the tolerable upper intake level for manganese
EFSA Journal, vol. 21, no. 12, e8413Contributions to Journals: ArticlesHabitual consumption of high-fibre bread fortified with bean hulls increased plasma indole-3-propionic concentration and decreased putrescine and deoxycholic acid faecal concentrations in healthy volunteers
British Journal of Nutrition, vol. 130, no. 9, pp. 1521-1536Contributions to Journals: ArticlesSafety of the extension of use of 2'-fucosyllactose (2'-FL) as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal, vol. 21, no. 11, e08334Contributions to Journals: ArticlesSafety of 2'-fucosyllactose (2'-FL) produced by a derivative strain (Escherichia coli SGR5) of E. coli W (ATCC 9637) as a Novel Food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 11, e08333Contributions to Journals: ArticlesSafety of a change in specifications of the novel food oleoresin from Haematococcus pluvialis containing astaxanthin pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 11, e08338Contributions to Journals: ArticlesSafety of an extension of use of Yarrowia lipolytica yeast biomass as a novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 11, e8416Contributions to Journals: ArticlesSafety of monosodium salt of l-5-methyltetrahydrofolic acid as a novel food pursuant to Regulation (EU) 2015/2283 and the bioavailability of folate from this source in the context of Directive 2002/46/EC, Regulation (EU) No 609/2013 and Regulation (EC) No 1925/2006
EFSA Journal, vol. 21, no. 11, e8417Contributions to Journals: ArticlesScientific opinion on the tolerable upper intake level for folate
EFSA Journal, vol. 21, no. 11, e08353Contributions to Journals: ArticlesAppethyl® and reduction of body weight: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
EFSA Journal, vol. 21, no. 10, e08239Contributions to Journals: ArticlesMorning exercise and pre-breakfast metformin interact to reduce glycaemia in people with Type 2 Diabetes: a randomized crossover trial
Working Papers: Preprint PapersRe-evaluation of behenic acid from mustard seeds to be used in the manufacturing of certain emulsifiers pursuant to Article 21(2) of Regulation (EU) No 1169/2011: for permanent exemption from labelling
EFSA Journal, vol. 21, no. 9, e08240Contributions to Journals: ArticlesSafety of 3'-sialyllactose (3'-SL) sodium salt produced by a derivative strain (Escherichia coli NEO3) of E. coli W (ATCC 9637) as a Novel Food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 9, e08224Contributions to Journals: ArticlesSafety of partially hydrolysed protein from spent barley (Hordeum vulgare) and rice (Oryza sativa) as a novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 9, e08064Contributions to Journals: ArticlesScientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate
EFSA Journal, vol. 21, no. 8, e08145Contributions to Journals: ArticlesCholine and contribution to normal liver function of the foetus and exclusively breastfed infants: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
EFSA Journal, vol. 21, no. 7, e08115Contributions to Journals: ArticlesNutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V
EFSA Journal, vol. 21, no. 7, e08063Contributions to Journals: ArticlesSafety of an ethanolic extract of the dried biomass of the microalga Phaeodactylum tricornutum as a novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 7, e08072Contributions to Journals: ArticlesSafety of apple fruit cell culture biomass as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal, vol. 21, no. 7, e08065Contributions to Journals: ArticlesSafety of 6'-sialyllactose (6'-SL) sodium salt produced by a derivative strain (Escherichia coli NEO6) of E. coli W (ATCC 9637) as a Novel Food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 6, e08025Contributions to Journals: ArticlesSafety of 3-fucosyllactose (3-FL) produced by a derivative strain of Escherichia coli K-12 DH1 as a novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 6, e08026Contributions to Journals: ArticlesSafety of UV-treated powder of whole yellow mealworm (Tenebrio molitor larva) as a novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 6, e08009Contributions to Journals: ArticlesSafety of paramylon as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal, vol. 21, no. 5, e07995Contributions to Journals: ArticlesSafety of yellow/orange tomato extract as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal, vol. 21, no. 5, e07994Contributions to Journals: ArticlesScientific opinion on the tolerable upper intake level for vitamin B6
EFSA Journal, vol. 21, no. 5, e08006Contributions to Journals: ArticlesSafety of the extension of use of partially defatted chia seed (Salvia hispanica L.) powder with a high fibre content as a novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 4, e07904Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.2903/j.efsa.2023.7904
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/20637/1/EFSAJ_Safety_of_VOR.pdf
Safety of water lentil protein concentrate from a mixture of Lemna gibba and Lemna minor as a novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 21, no. 4, e07903Contributions to Journals: ArticlesScientific opinion on the tolerable upper intake level for selenium
EFSA Journal, vol. 21, no. 1, e07704Contributions to Journals: ArticlesSafety of whole seeds of oilseed rape (Brassica napus L emend. Metzg.) as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal, vol. 21, no. 1, e07706Contributions to Journals: ArticlesSafety of 2'-fucosyllactose (2'-FL) produced by a derivative strain (APC199) of Corynebacterium glutamicumATCC 13032 as a novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 20, no. 12, e07647Contributions to Journals: ArticlesSafety of 6'-sialyllactose (6'-SL) sodium salt produced by derivative strains of Escherichia coli BL21 (DE3) as a novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 20, no. 12, e07645Contributions to Journals: ArticlesSafety of Lemna minor and Lemna gibba whole plant material as a novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, vol. 20, no. 11, e07598Contributions to Journals: ArticlesSafety of an aqueous ethanolic extract of Labisia pumila as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal, vol. 20, no. 11, e07611Contributions to Journals: ArticlesSafety of cellobiose as a novel food pursuant to regulation (EU) 2015/2283
EFSA Journal, vol. 20, no. 11, e07596Contributions to Journals: ArticlesSafety of β-hydroxybutyrate salts as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal, vol. 20, no. 10, e07449Contributions to Journals: ArticlesSafety of iron milk proteinate as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of iron from this source in the context of Directive 2002/46/EC
EFSA Journal, vol. 20, no. 9, e07549Contributions to Journals: ArticlesConversion of calcium-l-methylfolate and (6S)-5-methyltetrahydrofolic acid glucosamine salt into dietary folate equivalents
EFSA Journal, vol. 20Contributions to Specialist Publications: ArticlesLycopene-rich diets modulate HDL functionality and associated inflammatory markers without affecting lipoprotein size and distribution in moderately overweight, disease-free, middle-aged adults: a randomized controlled trial
Frontiers in Nutrition, vol. 9, 95459Contributions to Journals: ArticlesSafety of an extension of use of Yarrowia lipolytica yeast biomass as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal, vol. 20, no. 7, e07450Contributions to Journals: ArticlesSafety of frozen and freeze-dried formulations of the lesser mealworm ( Alphitobius diaperinus larva) as a Novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal, vol. 20, no. 7, e07325Contributions to Journals: ArticlesMarine-derived n-3 fatty acids therapy for stroke (Review-Intervention)
The Cochrane database of systematic reviews, vol. 2022, no. 6, CD012815Contributions to Journals: Review articlesSafety of freeze-dried mycelia of Antrodia camphorata as a novel food pursuant to regulation (EU) 2015/2283
EFSA Journal, vol. 20, no. 6, e07380Contributions to Journals: ArticlesSafety of vitamin D2 mushroom powder as a Novel food pursuant to Regulation (EU) 2015/2283 (NF 2019/1471).
EFSA Journal, vol. 20, no. 6, e07326Contributions to Journals: ArticlesSafety of zinc l-carnosine as a Novel food pursuant to Regulation (EU) 2015/2283 and the bioavailability of zinc from this source in the context of Directive 2002/46/EC on food supplements
EFSA Journal, vol. 20, no. 6, e07332Contributions to Journals: Articles